Surgical Excision versus Curettage plus Cryosurgery in the Treatment of Basal Cell Carcinoma

Kuijpers, Daniëlle; Thissen, M. R. T. M.; Berretty, P. J. M.; Ideler, Fons H. L. B.; Nelemans, Patty J.; Neumann, Martino

doi:10.1111/j.1524-4725.2007.33117.x

Cited by 48 publications

(45 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…24,54 Due to generally poorer treatment outcomes when compared with surgical excision, cryosurgery for treatment of primary head and neck lesions or high-risk BCC is not generally indicated unless thermocouples are used to document tissue temperature and the physician has extensive training/experience with the technique. 55,56 Curettage is often combined with cryosurgery, which may improve cure rates relative to cryosurgery alone. 57 …”

Section: Cryosurgerymentioning

confidence: 99%

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

et al. 2015

View full text Add to dashboard Cite

Background: Basal cell carcinoma (BCC) is the most common malignancy. Growth of BCCs leads to local destruction of neighbouring healthy skin and underlying tissue and can result in significant functional and cosmetic morbidity. Objective: To provide guidance to Canadian health care practitioners regarding management of BCCs. Methods: Literature searches and development of graded recommendations were carried out as discussed in the accompanying Introduction. Results: Although BCCs rarely metastasize, they can be aggressive and disfiguring. This chapter describes the natural history and prognosis of BCCs. Risk stratification is based on clinical features, including the site and size of the tumour, its histologic subtype (nodular vs sclerosing), and its history of recurrence. Conclusions: Various options should be considered for BCC treatment, including cryosurgery, curettage, and topical or photodynamic approaches, as well as fixed-margin surgery and Mohs micrographic surgery. Stratification of recurrence risk for individual BCCs determines the most appropriate therapeutic course. RésuméContexte : Le carcinome basocellulaire (CBC) est le cancer le plus répandu. La croissance d'un CBC mène à la destruction locale de la peau saine environnante et des tissus sous-jacents et peut causer une morbidité fonctionnelle et cosmétique importante. Objectif : Fournir des conseils aux professionnels canadiens de la santé au sujet de la gestion des CBC. Méthode : Nous avons procédé à une étude documentaire et à l'élaboration de catégories de recommandations, comme on peut le lire dans l'introduction connexe. Résultats : Le CBC forme rarement des métastases, mais il peut être agressif et défigurant. Ce chapitre décrit l'évolution et le pronostic du CBC. La stratification du risque est fondée sur les caractéristiques cliniques, y compris l'emplacement et la taille de la tumeur, et son sous-type histologique (nodulaire ou sclérosant), et sur les antécédents de récurrence. Conclusion : Diverses options devraient être envisagées dans le traitement du CBC, y compris la cryochirurgie, le curetage et les approches topiques ou photodynamiques, ainsi que la chirurgie à marge déterminée et la chirurgie micrographique de Mohs. La stratification du risque de récurrence de chaque CBC individuel détermine le traitement thérapeutique le plus approprié.

show abstract

Section: Cryosurgerymentioning

confidence: 99%

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

et al. 2015

View full text Add to dashboard Cite

show abstract

“…40 Moreover, EDC has been associated with inferior cosmetic outcome compared to excisional treatments. 46 Imiquimod has been touted as a relatively inexpensive, nonsurgical treatment for NMSC. 47 However, this treatment also has many limitations to its general use.…”

Section: Discussionmentioning

confidence: 99%

A relative value unit–based cost comparison of treatment modalities for nonmelanoma skin cancer: Effect of the loss of the Mohs multiple surgery reduction exemption

Rogers

Coldiron

2009

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…3 Multiple RCTs comparing standard surgical excision of BCC with topical medical therapy, C&E, photodynamic therapy (PDT), cryotherapy, radiation therapy, and MMS have been published. 32,[34][35][36][37][38][39] All the studies consistently reported low recurrence rates after standard excision of BCC with predominantly nonaggressive histologic growth patterns. Excision of nodular or superficial BCC with 3-to 4-mm margins in low-risk anatomic locations was associated with 2% to 4% recurrence rates after 3 to 5 years.…”

Section: Standard Excisionmentioning

confidence: 94%

“…35,[38][39][40] In a study comparing standard excision with C&E followed by cryosurgery for nonaggressive BCC on the head and neck, the 5-year recurrence rates were 8.2% and 17.6%, respectively. 36 Recurrence rates following surgical excision were uniformly significantly lower than those following treatment with topical therapy, radiation therapy, or destructive modalities. Only MMS was superior to standard excision for the treatment of primary and recurrent facial BCC after 5-and 10-years of follow-up.…”

Section: Standard Excisionmentioning

confidence: 97%

Guidelines of care for the management of basal cell carcinoma

Baum¹,

Bordeaux²,

Brown³

et al. 2018

Journal of the American Academy of Dermatology

311

219

View full text Add to dashboard Cite

Basal cell carcinoma (BCC) is the most common form of human cancer, with a continually increasing annual incidence in the United States. When diagnosed early, the majority of BCCs are readily treated with office-based therapy, which is highly curative. In these evidence-based guidelines of care, we provide recommendations for the management of patients with BCC, as well as an in-depth review of the best available literature in support of these recommendations. We discuss biopsy techniques for a clinically suspicious lesion and offer recommendations for the histopathologic interpretation of BCC. In the absence of a formal staging system, the best available stratification based on risk for recurrence is reviewed. With regard to treatment, we provide recommendations on treatment modalities along a broad therapeutic spectrum, ranging from topical agents and superficially destructive modalities to surgical techniques and systemic therapy. Finally, we review the available literature and provide recommendations on prevention and the most appropriate follow-up for patients in whom BCC has been diagnosed. ( J Am Acad Dermatol

show abstract

Surgical Excision versus Curettage plus Cryosurgery in the Treatment of Basal Cell Carcinoma

Cited by 48 publications

References 38 publications

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

Non-melanoma Skin Cancer in Canada Chapter 4: Management of Basal Cell Carcinoma

A relative value unit–based cost comparison of treatment modalities for nonmelanoma skin cancer: Effect of the loss of the Mohs multiple surgery reduction exemption

Guidelines of care for the management of basal cell carcinoma

Contact Info

Product

Resources

About